Viewing Study NCT01453504


Ignite Creation Date: 2025-12-24 @ 9:16 PM
Ignite Modification Date: 2026-02-08 @ 11:11 AM
Study NCT ID: NCT01453504
Status: COMPLETED
Last Update Posted: 2019-11-08
First Post: 2011-10-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Everolimus in Combination With DHAP in Patients With Relapsed or Refractory Hodgkin Lymphoma
Sponsor: University of Cologne
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hodgkin Lymphoma View
Keywords: